Schering-Plough

Income, access to drugs and management plans affect asthma control across age groups, study shows

While most stocks have nosedived this year, a few have gained altitude. Many, but by no means all, are energy stocks. And not all of them are expensive, either. Here are five stocks that are bucking the downtrend. Exxon As I write this, the market is down about 20% for

The Vanguard Network welcomes professor of Early American History Robert A. Gross on June 30 from 4 - 5:30 PM ET, for an online dialogue, as part of the "A Different Kind of Leadership" series.

If the ineffective decongestant phenylephrine is removed from the market, other over-the-counter drugs could be up for reevaluation next.

The onetime Silicon Valley star is expected to surrender herself to federal authorities at the Bryan, Texas, prison camp, an all-female facility about 100 miles outside of Houston.

Life Sciences leaders to gather in Cambridge, MA for a confidential, highly-interactive looks at the future of the industry. Hosted by The Vanguard Network.

A refreshment of the board may be on the horizon at the animal health company.

An Online Dialogue Presented by The Vanguard Network on January 20, 2022.

After nearly four months of court proceedings in one of the most high-profile tech trials in recent memory, Elizabeth Holmes has been found guilty on four out of 11 federal fraud and conspiracy charges.

Patients with Crohn's disease who are considered high-risk as determined by capsule endoscopy but are in clinical remission benefit from a treat-to-target strategy, a new study shows.

A loophole in FDA processes means older drugs like the ones in oral decongestants weren't properly tested. Here's how we learned the most popular one doesn't work

General Counsels will come together to discuss the changing and expanding role of the chief legal officer today. The Vanguard Forum is an opportunity for these senior executives to share real-world challenges and craft solutions.

While investors who make strategic investments in undervalued companies can transform said business as well as their own portfolio, investors who make strategic investments in companies with an ethical purpose can change the world.

The series, designed to foster international leadership skills, kicks off on March 2 with Richard Schatzberg, Chief Commercial Officer of NeST Technologies

Good outcomes generally maintained for up to two decades

There are benefits of studying certain biological processes under microgravity, but whether those advantages outweigh the costs of getting experiments off Earth remains to be seen.

The current (public) receipts are included in this essay, and more are on the way

The new book "For Blood and Money" shows how two drugs bought for as little as $1,000 turned into multi-billion dollar blockbusters that made a difference for cancer patients.

Here are five stocks that are bucking the market downtrend.

Promoting diversity in the life sciences is not just the right thing to do -- it stimulates innovation. Join this interactive online Vanguard dialogue with Paul Hastings, chair of BIO; CEO of Nkarta and key sponsor of OUTBio!, the biotech industry's largest LGBTQ professionals group.